Fortive 10-Q 2023-06-30
Filed 2023-07-26. 8 sections, 166K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________
FORM 10-Q
| (Mark One) | |||||
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended: June 30, 2023
| Or | |||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| For the transition period from to |
Commission file number 1-37654
Fortive Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 47-5654583 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. employer identification number) |
| 6920 Seaway Blvd | |||||||||||
| Everett, | WA | 98203 | |||||||||
| (Address of principal executive offices) | (Zip code) |
Registrant’s telephone number, including area code: (425) 446-5000
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||
| Common stock, par value $0.01 per share | FTV | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of common stock outstanding at July 21, 2023 was 352,024,375.
FORTIVE CORPORATION
INDEX
FORM 10-Q
PART I - FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
FORTIVE CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
($ in millions, except share and per share amounts)
| As of | |||||||||||
| June 30, 2023 | December 31, 2022 | ||||||||||
| (unaudited) | |||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and equivalents | $ | 712.8 | $ | 709.2 | |||||||
| Trade accounts receivable less allowance for doubtful accounts of $40.4 at June 30, 2023 and $43.9 at December 31, 2022 | 935.2 | 958.5 | |||||||||
| Inventories: | |||||||||||
| Finished goods | 231.2 | 215.3 | |||||||||
| Work in process | 105.2 | 96.4 | |||||||||
| Raw materials | 224.8 | 225.0 | |||||||||
| Inventories | 561.2 | 536.7 | |||||||||
| Prepaid expenses and other current assets | 265.4 | 272.6 | |||||||||
| Total current assets | 2,474.6 | 2,477.0 | |||||||||
| Property, plant and equipment, net of accumulated depreciation of $789.2 at June 30, 2023 and $754.5 at December 31, 2022 | 425.9 | 421.9 | |||||||||
| Other assets | 474.3 | 455.8 | |||||||||
| Goodwill | 9,051.9 | 9,048.5 | |||||||||
| Other intangible assets, net | 3,304.0 | 3,487.4 | |||||||||
| Total assets | $ | 15,730.7 | $ | 15,890.6 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Current portion of long-term debt | $ | 999.9 | $ | 999.7 | |||||||
| Trade accounts payable | 585.6 | 623.0 | |||||||||
| Accrued expenses and other current liabilities | 999.5 | 1,104.4 | |||||||||
| Total current liabilities | 2,585.0 | 2,727.1 | |||||||||
| Other long-term liabilities | 1,195.7 | 1,223.3 | |||||||||
| Long-term debt | 1,978.2 | 2,251.6 | |||||||||
| Commitments and Contingencies (Note 8) | |||||||||||
| Equity: | |||||||||||
| Common stock: $0.01 par value, 2.0 billion shares authorized; 362.7 million issued and 351.9 million outstanding at June 30, 2023; 361.5 million issued and 352.9 million outstanding at December 31, 2022 | 3.6 | 3.6 | |||||||||
| Additional paid-in capital | 3,778.7 | 3,706.3 | |||||||||
| Treasury shares, at cost | (572.0) | (442.9) | |||||||||
| Retained earnings | 7,075.4 | 6,742.1 | |||||||||
| Accumulated other comprehensive loss | (319.9) | (325.7) | |||||||||
| Total Fortive stockholders’ equity | 9,965.8 | 9,683.4 | |||||||||
| Noncontrolling interests | 6.0 | 5.2 | |||||||||
| Total stockholders’ equity | 9,971.8 | 9,688.6 | |||||||||
| Total liabilities and equity | $ | 15,730.7 | $ | 15,890.6 |
See the accompanying Notes to Consolidated Condensed Financial Statements.
FORTIVE CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, 2023 | July 1, 2022 | June 30, 2023 | July 1, 2022 | ||||||||||||||||||||
| Sales of products and software | $ | 1,290.8 | $ | 1,229.4 | $ | 2,527.4 | $ | 2,382.1 | |||||||||||||||
| Sales of services | 235.6 | 233.9 | 459.7 | 457.7 | |||||||||||||||||||
| Total sales | 1,526.4 | 1,463.3 | 2,987.1 | 2,839.8 | |||||||||||||||||||
| Cost of product and software sales | (500.1) | (508.3) | (985.2) | (973.4) | |||||||||||||||||||
| Cost of service sales | (120.9) | (121.5) | (248.3) | (240.9) | |||||||||||||||||||
| Total cost of sales | (621.0) | (629.8) | (1,233.5) | (1,214.3) | |||||||||||||||||||
| Gross profit | 905.4 | 833.5 | 1,753.6 | 1,625.5 | |||||||||||||||||||
| Operating costs: | |||||||||||||||||||||||
| Selling, general and administrative expenses | (514.0) | (484.9) | (1,021.7) | (965.5) | |||||||||||||||||||
| Research and development expenses | (100.1) | (100.1) | (200.2) | (199.2) | |||||||||||||||||||
| Russia exit and wind down costs | — | (16.2) | — | (16.2) | |||||||||||||||||||
| Operating profit | 291.3 | 232.3 | 531.7 | 444.6 | |||||||||||||||||||
| Non-operating income (expense), net: | |||||||||||||||||||||||
| Interest expense, net | (33.1) | (21.0) | (65.2) | (39.8) | |||||||||||||||||||
| Other non-operating expense, net | (7.8) | (3.1) | (10.3) | (5.8) | |||||||||||||||||||
| Earnings before income taxes | 250.4 | 208.2 | 456.2 | 399.0 | |||||||||||||||||||
| Income taxes | (41.4) | (35.2) | (73.6) | (60.9) | |||||||||||||||||||
| Net earnings | $ | 209.0 | $ | 173.0 | $ | 382.6 | $ | 338.1 | |||||||||||||||
| Net earnings per share: | |||||||||||||||||||||||
| Basic | $ | 0.59 | $ | 0.48 | $ | 1.08 | $ | 0.94 | |||||||||||||||
| Diluted | $ | 0.59 | $ | 0.48 | $ | 1.07 | $ | 0.93 | |||||||||||||||
| Average common stock and common equivalent shares outstanding: | |||||||||||||||||||||||
| Basic | 353.0 | 357.4 | 353.3 | 358.3 | |||||||||||||||||||
| Diluted | 355.5 | 359.8 | 356.0 | 364.2 | |||||||||||||||||||
See the accompanying Notes to Consolidated Condensed Financial Statements.
FORTIVE CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
($ in millions)
(unaudited)
| Three Months Ended | Six Months Ended |
Showing the first 8K of 85K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Fortive Corporation (“Fortive,” the “Company,” “we,” “us,” or “our”) is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. Our strategic segments - Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions - include well-known brands with leading positions in their markets. Our businesses design, develop, manufacture, and service professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. We are headquartered in Everett, Washington and employ a team of more than 18,000 research and development, manufacturing, sales, distribution, service, and administrative employees in more than 50 countries around the world.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of management. The following discussion should be read in conjunction with the MD&A and consolidated financial statements included in our 2022 Annual Report on Form 10-K. Our MD&A is divided into five sections:
-
Information Relating to Forward-Looking Statements
-
Overview
-
Results of Operations
-
Liquidity and Capital Resources
-
Critical Accounting Estimates
INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this quarterly report, in other documents we file with or furnish to the Securities and Exchange Commission (“SEC”), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are “forward-looking statements” within the meaning of the United States federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into, including the expected impact of trade and tariff policies; new or modified laws, regulations and accounting pronouncements; impact of climate-related events or transition activities; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; impact of changes to tax laws; general economic and capital markets conditions, including impact of inflation or interest rate changes; impact of geopolitical events, including the impact of Ukraine/Russia conflict and other hostilities; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words.
Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Important factors that could cause actual results to differ materially from those envisaged in the forward-looking statements include, among others, the following:
Risk Related to Our Business Operations
-
Conditions in the global economy, the markets we serve, and the financial markets and banking systems may adversely affect our business and financial statements.
-
If we cannot adjust our manufacturing capacity, supply chain management or the purchases required for our manufacturing activities to reflect changes in market conditions, customer demand and supply chain or transportation disruptions, our profitability may suffer. In addition, our reliance upon sole or limited sources of supply for certain materials, components, and services could cause production interruptions, delays and inefficiencies.
-
Our financial results are subject to fluctuations in the cost and availability of commodities or components that we use in our operations.
-
Any resurgence in the spread of COVID-19 and the corresponding constraints on supply chain, labor force, and the operations of our customers, suppliers, and vendors could have an adverse impact on our business and results of operations.
-
Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated, or experience cyclicality.
-
We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce prices for our products and services.
-
Our growth depends in part on the timely development and commercialization and customer acceptance of new and enhanced products and services based on technological innovation.
-
If we are unable to recruit and retain key employees, our business may be harmed.
-
A significant disruption in, or breach in security of, our information technology systems could adversely affect our business.
-
Defects and unanticipated use or inadequate disclosure with respect to our products (including software) or services could adversely affect our business, reputation, and financial statements.
-
Adverse changes in our relationships with, or the financial condition, performance, purchasing patterns, or inventory levels of, key distributors and other channel partners could adversely affect our financial statements.
-
Our restructuring activities could have long-term adverse effects on our business.
-
Work stoppages, works council campaigns, and other labor disputes could adversely impact our productivity and results of operations.
-
If we suffer loss to our facilities, supply chains, distribution systems, or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
-
If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
-
Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses, or licensing expenses or be prevented from selling products or services.
-
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our financial statements.
Risk Related to our International Operations
-
International economic, political, legal, compliance, and business factors could negatively affect our financial statements.
-
Trade relations between China and the United States coul
Showing the first 8K of 65K characters. Open the full section
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our concentrations of credit risk arising from trade receivables is limited due to the diversity of our customers. Our businesses perform credit evaluations of their customers’ financial conditions as appropriate and also obtain collateral or other security when appropriate.
Additional quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Financial Instruments and Risk Management,” in our 2022 Annual Report on Form 10-K. There were no material changes during the three and six-month periods ended June 30, 2023 to the information reported in our 2022 Annual Report on Form 10-K relating to our evaluation of interest rate, foreign currency exchange, and commodity price risk. Refer to Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for discussion around the impact of these items in the first quarter.
Item 4. CONTROLS AND PROCEDURES
Our management, with the participation of the President and Chief Executive Officer, and the Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the President and Chief Executive Officer, and the Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, these disclosure controls and procedures were effective.
There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1A. RISK FACTORS
Information regarding risk factors appears in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Information Relating to Forward-Looking Statements,” in Part I - Item 2 of this Form 10-Q and in the “Risk Factors” section of our 2022 Annual Report on Form 10-K. There were no material changes during the quarter and year-to-date period ended June 30, 2023 to the risk factors reported in the “Risk Factors” section of our 2022 Annual Report on Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On February 17, 2022, the Company's Board of Directors approved a share repurchase program authorizing the Company to repurchase up to 20 million shares of the Company's outstanding common stock from time to time on the open market or in privately negotiated transactions, with 11 million shares remaining authorized under the share repurchase program as of June 30, 2023. There is no expiration date for the repurchase program, and the timing and amount of repurchases under the program are determined by the Company's management based on market conditions and other factors. The repurchase program may be suspended or discontinued at any time by the Board of Directors. During the year-to-date period ended June 30, 2023, the Company purchased 2 million shares of its common stock at an average price of $64.54. As of June 30, 2023, there were 11 million shares remaining for repurchase under the program.
The following table provides details about our share repurchases during the fiscal quarter ended June 30, 2023.
| Period | Total number of shares (or units) purchased | Average price paid per share (or unit) | Total number of shares (or units) purchased as part of publicly announced plans or programs | Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs | |||||||||||||||||||
| Apr 2 - Apr 30 | — | $ | — | N/A | N/A | ||||||||||||||||||
| May 1 - May 31 | 2,000,000 | 64.54 | 2,000,000 | 11,000,000 | |||||||||||||||||||
| June 1 - June 30 | — | — | N/A | N/A | |||||||||||||||||||
| Total | 2,000,000 | $ | 64.54 | 2,000,000 | 11,000,000 | ||||||||||||||||||
Item 5. OTHER INFORMATION
(c) Trading Plans
During the second quarter ended June 30, 2023, none of the Company’s directors or Section 16 officers adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. EXHIBITS
- Indicates management contract or compensatory plan, contract or arrangement
(1) Exhibit 101 to this report includes the following documents formatted in Inline XBRL (Extensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets as of June 30, 2023 and December 31, 2022, (ii) Consolidated Condensed Statements of Earnings for the three and six-month periods ended June 30, 2023 and July 1, 2022, (iii) Consolidated Condensed Statements of Comprehensive Income for the three and six-month periods ended June 30, 2023 and July 1, 2022, (iv) Consolidated Condensed Statement of Changes in Equity for the three and six-month periods ended June 30, 2023 and July 1, 2022, (v) Consolidated Condensed Statements of Cash Flows for the six-month periods ended June 30, 2023 and July 1, 2022, and (vi) Notes to Consolidated Condensed Financial Statements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| FORTIVE CORPORATION: | ||||||||
| Date: July 26, 2023 | By: | /s/ Charles E. McLaughlin | ||||||
| Charles E. McLaughlin | ||||||||
| Senior Vice President and Chief Financial Officer | ||||||||
| Date: July 26, 2023 | By: | /s/ Christopher M. Mulhall | ||||||
| Christopher M. Mulhall | ||||||||
| Chief Accounting Officer | ||||||||